New drug siplizumab tested in ALS patients – early trial begins
Disease control
Recruiting now
This early-stage trial tests the safety of siplizumab, a drug that may calm the immune system, in 48 adults newly diagnosed with ALS. Researchers will monitor side effects and how the drug moves through the body. The goal is to see if it is safe enough for larger studies.
Phase: PHASE1 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC